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was similar to that observed in studies that were not limit-
ed to specimens that had already tested negative for other
microorganisms and in which a wide number of agents
were investigated (4). Adenoviruses have been associated
with infection of the colon and the gut and are a cause of
severe gastroenteritis in nonindustrialized countries. In this
study, coinfection of adenovirus and HBoV was detected
in 1 respiratory specimen but these viruses together were
not detected in any fecal sample.
HBoV and parvovirus B19 are the only 2 species of
the Parvoviridae family that have been associated with
disease in humans. To date, HBoV has only been detected
in samples from the respiratory tract and has been associ-
ated with both upper and lower respiratory tract disease in
infants and young children. The results of our study show
that HBoV is also present in the gastrointestinal tract in
children with gastroenteritis with or without symptoms of
respiratory infection. The fecal excretion adds new con-
cern about the transmission of HBoV.
To our knowledge, this report is the first to document
HBoV in human feces. The high frequency of HBoV
detection in the feces of children with gastroenteritis and
the absence of any other intestinal pathogen suggest that
this new virus species is an enteric, as well as a respirato-
ry, pathogen. Further investigations to confirm this prelim-
inary hypothesis and gain greater knowledge of the
association between HBoV and enteric disease are
required.
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Human Bocavirus and Gastroenteritis
Bocavirus
Genus in the family Parvoviridae. Previously identi-
fied members of this genus are pathogens of bovines
and canines. A parvovirus of human origin was
recently discovered and called human bocavirus
because it is closely related to bovine parvovirus and
canine minute virus. Human bocavirus is associated
with respiratory tract infections, particularly in infants
and young children. 
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